Could less medicine be better? major trial tests lower doses for blood cancers
Disease control
Not yet recruiting
This large trial aims to find the best dose for blood cancer drugs, testing if lower doses can control the disease just as well while causing fewer side effects. It will enroll 400 adults with conditions like multiple myeloma and Waldenstrom's macroglobulinemia. The study uses a …
Phase: PHASE4 • Sponsor: Anne Louise Tølbøll Sørensen • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC